Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
BMC Gastroenterology
|
January 13, 2025
Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis
Ye Liu, Ziwei Chen, Chang Li, et al.
Peptides
|
February 5, 2011
Urotensin II inhibits the proliferation but not the differentiation of cardiac side population cells
Hui Gong, Hong Ma, Meilan Liu, et al.
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
International Journal of Molecular Sciences
|
March 13, 2025
MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer
Breanna McBean, Reine Abou Zeidane, Samuel Lichtman-Mikol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
Corey Speers, Shuang G Zhao, Vishal Kothari, et al.
Frontiers in Immunology
|
September 6, 2021
Long Noncoding RNA RP11-115N4.1 Promotes Inflammatory Responses by Interacting With HNRNPH3 and Enhancing the Transcription of HSP70 in Unexplained Recurrent Spontaneous Abortion
Meilan Liu, Xiaoyue Sun, Liqiong Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences
Corey Speers, S Laura Chang, Andrea Pesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2020
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers
Andrea M Pesch, Nicole H Hirsh, Benjamin C Chandler, et al.
Molecular Cancer Therapeutics
|
August 16, 2019
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
Anna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, et al.
NPJ Breast Cancer
|
August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
Corey Speers, Shuang G Zhao, Ben Chandler, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
BMC Gastroenterology
|
January 13, 2025
Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis
Ye Liu, Ziwei Chen, Chang Li, et al.
Peptides
|
February 5, 2011
Urotensin II inhibits the proliferation but not the differentiation of cardiac side population cells
Hui Gong, Hong Ma, Meilan Liu, et al.
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
International Journal of Molecular Sciences
|
March 13, 2025
MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer
Breanna McBean, Reine Abou Zeidane, Samuel Lichtman-Mikol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
Corey Speers, Shuang G Zhao, Vishal Kothari, et al.
Frontiers in Immunology
|
September 6, 2021
Long Noncoding RNA RP11-115N4.1 Promotes Inflammatory Responses by Interacting With HNRNPH3 and Enhancing the Transcription of HSP70 in Unexplained Recurrent Spontaneous Abortion
Meilan Liu, Xiaoyue Sun, Liqiong Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences
Corey Speers, S Laura Chang, Andrea Pesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2020
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers
Andrea M Pesch, Nicole H Hirsh, Benjamin C Chandler, et al.
Molecular Cancer Therapeutics
|
August 16, 2019
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
Anna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, et al.
NPJ Breast Cancer
|
August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
Corey Speers, Shuang G Zhao, Ben Chandler, et al.
Page
of 7